NCT02050711

Brief Summary

The effect of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD) has been based on systemic outcome measures, however, little is known about the effectiveness of this intervention on patients' lung function. The forced expiratory volume in one second (FEV1), despite of being the gold standard for assessing lung function in COPD, is poorly responsive to pulmonary rehabilitation. Thus, an objective and responsive outcome measure to assess the effect of pulmonary rehabilitation on lung function is needed. Computerized respiratory sounds have been found to be a more sensitive indicator, detecting and characterizing the severity of respiratory diseases before any other measure, however its potential to detect changes after pulmonary rehabilitation has never been explored. Therefore, this study aims to assess the effects of pulmonary rehabilitation on the characteristics of computerized respiratory sounds in patients with COPD. A randomized controlled study with one group undergoing pulmonary rehabilitation (n=25) and other group receiving standard care (n=25) will be conducted. The pulmonary rehabilitation program will included exercise training (3\*week) and psychoeducation (1\*week). Computerized respiratory sounds, lung function, exercise capacity, quadriceps muscle strength, health-related quality of life and health services use will be assessed in both groups, at baseline, immediately post-intervention and at follow-ups (3 and 6 months after PR). Descriptive and inferential statistics will be used. It is expected that significant changes occur on the characteristics of computerized respiratory sounds in patients enrolled in the pulmonary rehabilitation group, in comparison with patients receiving standard care. Thus, computerized respiratory sounds could provide a simple, objective and non-invasive measure to assess lung function changes after pulmonary rehabilitation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2013

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 28, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 31, 2014

Completed
Last Updated

January 23, 2018

Status Verified

January 1, 2018

Enrollment Period

3.6 years

First QC Date

January 28, 2014

Last Update Submit

January 18, 2018

Conditions

Keywords

Chronic obstructive pulmonary disease (COPD)Pulmonary rehabilitationComputerized respiratory sounds

Outcome Measures

Primary Outcomes (1)

  • Change in respiratory sounds

    Computerized respiratory sounds will be recorded with modified stethoscopes at seven chest locations: trachea; posterior right and left; anterior right and left and lateral right and left, as recommended by the Computerized Respiratory Sound Analysis (CORSA) guidelines.

    1 week prior intervention; 1, 12 and 24 weeks post intervention

Secondary Outcomes (5)

  • Change in lung function

    1 week prior intervention; 1, 12 and 24 weeks post intervention

  • Change in exercise capacity

    1 week prior intervention; 1, 12 and 24 weeks post intervention

  • Change in quadriceps muscle strength

    1 week prior intervention; 1, 12 and 24 weeks post intervention

  • Change in health-related quality of life

    1 week prior intervention; 1, 12 and 24 weeks post intervention

  • Change in health services use

    1 week prior intervention; 1, 12 and 24 weeks post intervention

Study Arms (2)

Usual care

OTHER

Patients will receive usual care from their general practitioners/pulmonologists.

Other: Usual care

Pulmonary rehabilitation

EXPERIMENTAL

Patients will enrol in a 12-week PR program consisting on exercise training (3 times a week) and psychoeducation (once a week).

Behavioral: Pulmonary rehabilitation

Interventions

Pulmonary rehabilitation
Usual care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinical diagnosis of COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria;
  • ≥ 18 years old;
  • clinical stability for 1 month prior to the study (no hospital admissions, exacerbations or changes in medication);
  • able to provide their own informed consent.

You may not qualify if:

  • presence of concomitant respiratory diseases;
  • presence of severe psychiatric conditions;
  • presence of severe neurologic/ musculoskeletal conditions and/or unstable cardiovascular disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Aveiro

Aveiro, 3810-193, Portugal

Location

Related Publications (2)

  • Marques A, Oliveira A, Jacome C. Computerized adventitious respiratory sounds as outcome measures for respiratory therapy: a systematic review. Respir Care. 2014 May;59(5):765-76. doi: 10.4187/respcare.02765. Epub 2013 Sep 17.

    PMID: 24046460BACKGROUND
  • Jacome C, Marques A. Pulmonary rehabilitation for mild COPD: a systematic review. Respir Care. 2014 Apr;59(4):588-94. doi: 10.4187/respcare.02742. Epub 2013 Oct 8.

    PMID: 24106321BACKGROUND

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Alda S Marques, PhD

    School of Health Sciences of the University of Aveiro (ESSUA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer

Study Record Dates

First Submitted

January 28, 2014

First Posted

January 31, 2014

Study Start

September 1, 2009

Primary Completion

March 20, 2013

Study Completion

September 30, 2013

Last Updated

January 23, 2018

Record last verified: 2018-01

Locations